Pear Bio Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
Series A1
- Latest Deal Amount
-
$15M
- Investors
-
17
Pear Bio General Information
Description
Developer of a precision medicine platform designed to predict treatment response for cancer patients. The company utilizes tissue engineering, confocal microscopy, and computer vision to create patient-derived three-dimensional immune-microtumors, enabling oncology patients to identify effective therapies and pharmaceutical companies to discover novel therapeutic targets.
Contact Information
Website
www.pearbio.comCorporate Office
- ABI-LAB 2
- 22 Strathmore Road
- Natick, MA 01760
- United States
Corporate Office
- ABI-LAB 2
- 22 Strathmore Road
- Natick, MA 01760
- United States
Pear Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC (Series A1) | 22-Aug-2023 | $15M | Completed | Pre-Clinical Trials | ||
| 7. Accelerator/Incubator | Completed | Pre-Clinical Trials | ||||
| 6. Seed Round | Completed | Pre-Clinical Trials | ||||
| 5. Accelerator/Incubator | 19-Oct-2021 | Completed | Pre-Clinical Trials | |||
| 4. Accelerator/Incubator | 01-Jan-2020 | Completed | Pre-Clinical Trials | |||
| 3. Accelerator/Incubator | 20-Aug-2019 | Completed | Pre-Clinical Trials | |||
| 2. Accelerator/Incubator | Completed | Pre-Clinical Trials | ||||
| 1. Accelerator/Incubator | 01-Jan-2015 | Completed | Pre-Clinical Trials |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Pear Bio Signals
Pear Bio Investors (17)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Compound (New York) | Venture Capital | Minority | ||
| Covalent Ventures (CV) | Venture Capital | Minority | ||
| Crista Galli Ventures | Venture Capital | Minority | ||
| Earlymarket | Family Office | Minority | ||
| Fly Ventures | Venture Capital | Minority |
Pear Bio FAQs
-
When was Pear Bio founded?
Pear Bio was founded in 2015.
-
Where is Pear Bio headquartered?
Pear Bio is headquartered in Natick, MA.
-
What is the size of Pear Bio?
Pear Bio has 7 total employees.
-
What industry is Pear Bio in?
Pear Bio’s primary industry is Biotechnology.
-
Is Pear Bio a private or public company?
Pear Bio is a Private company.
-
What is the current valuation of Pear Bio?
The current valuation of Pear Bio is .
-
What is Pear Bio’s current revenue?
The current revenue for Pear Bio is .
-
How much funding has Pear Bio raised over time?
Pear Bio has raised $15.1M.
-
Who are Pear Bio’s investors?
Compound (New York), Covalent Ventures (CV), Crista Galli Ventures, Earlymarket, and Fly Ventures are 5 of 17 investors who have invested in Pear Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process